Titan Biotech Statistics

Total Valuation

Titan Biotech has a market cap or net worth of INR 3.49 billion. The enterprise value is 3.47 billion.

Market Cap	3.49B
Enterprise Value	3.47B

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Titan Biotech has 8.26 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class	8.26M
Shares Outstanding	8.26M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	8.82%
Owned by Institutions (%)	n/a
Float	2.65M

Valuation Ratios

The trailing PE ratio is 16.23.

PE Ratio	16.23
Forward PE	n/a
PS Ratio	2.23
PB Ratio	2.28
P/TBV Ratio	2.28
P/FCF Ratio	32.49
P/OCF Ratio	17.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.08, with an EV/FCF ratio of 32.23.

EV / Earnings	16.10
EV / Sales	2.22
EV / EBITDA	12.08
EV / EBIT	14.14
EV / FCF	32.23

Financial Position

The company has a current ratio of 4.46, with a Debt / Equity ratio of 0.02.

Current Ratio	4.46
Quick Ratio	1.37
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	0.26
Interest Coverage	26.51

Financial Efficiency

Return on equity (ROE) is 15.01% and return on invested capital (ROIC) is 8.92%.

Return on Equity (ROE)	15.01%
Return on Assets (ROA)	8.02%
Return on Invested Capital (ROIC)	8.92%
Return on Capital Employed (ROCE)	13.54%
Revenue Per Employee	3.48M
Profits Per Employee	479,546
Employee Count	449
Asset Turnover	0.94
Inventory Turnover	1.51

Taxes

In the past 12 months, Titan Biotech has paid 60.96 million in taxes.

Income Tax	60.96M
Effective Tax Rate	22.07%

Stock Price Statistics

The stock price has decreased by -19.32% in the last 52 weeks. The beta is 0.43, so Titan Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-19.32%
50-Day Moving Average	459.21
200-Day Moving Average	635.93
Relative Strength Index (RSI)	36.21
Average Volume (20 Days)	7,039

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Titan Biotech had revenue of INR 1.56 billion and earned 215.32 million in profits. Earnings per share was 26.06.

Revenue	1.56B
Gross Profit	838.23M
Operating Income	212.57M
Pretax Income	276.28M
Net Income	215.32M
EBITDA	254.26M
EBIT	212.57M
Earnings Per Share (EPS)	26.06

Full Income Statement

Balance Sheet

The company has 55.58 million in cash and 27.97 million in debt, giving a net cash position of 27.62 million or 3.34 per share.

Cash & Cash Equivalents	55.58M
Total Debt	27.97M
Net Cash	27.62M
Net Cash Per Share	3.34
Equity (Book Value)	1.53B
Book Value Per Share	185.75
Working Capital	613.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 201.23 million and capital expenditures -93.69 million, giving a free cash flow of 107.55 million.

Operating Cash Flow	201.23M
Capital Expenditures	-93.69M
Free Cash Flow	107.55M
FCF Per Share	13.01

Full Cash Flow Statement

Margins

Gross margin is 53.58%, with operating and profit margins of 13.59% and 13.76%.

Gross Margin	53.58%
Operating Margin	13.59%
Pretax Margin	17.66%
Profit Margin	13.76%
EBITDA Margin	16.25%
EBIT Margin	13.59%
FCF Margin	6.87%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.47%.

Dividend Per Share	2.00
Dividend Yield	0.47%
Dividend Growth (YoY)	11.11%
Years of Dividend Growth	2
Payout Ratio	7.68%
Buyback Yield	0.02%
Shareholder Yield	0.49%
Earnings Yield	6.16%
FCF Yield	3.08%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6